CHAMPIONS ONCOLOGY INC (CSBR) Stock Price & Overview
NASDAQ:CSBR • US15870P3073
Current stock price
The current stock price of CSBR is 6.2 USD. Today CSBR is down by -0.8%. In the past month the price increased by 5.98%. In the past year, price decreased by -35.28%.
CSBR Key Statistics
- Market Cap
- 86.118M
- P/E
- N/A
- Fwd P/E
- 60.78
- EPS (TTM)
- -0.05
- Dividend Yield
- N/A
CSBR Stock Performance
CSBR Stock Chart
CSBR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CSBR. When comparing the yearly performance of all stocks, CSBR is a bad performer in the overall market: 86.57% of all stocks are doing better.
CSBR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CSBR. While CSBR is still in line with the averages on profitability rating, there are concerns on its financial health.
CSBR Earnings
On March 12, 2026 CSBR reported an EPS of -0.02 and a revenue of 16.56M. The company missed EPS expectations (-121.79% surprise) and missed revenue expectations (-2.27% surprise).
CSBR Forecast & Estimates
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 97.42% is expected in the next year compared to the current price of 6.2.
For the next year, analysts expect an EPS growth of -72.8% and a revenue growth 3.41% for CSBR
CSBR Groups
Sector & Classification
CSBR Financial Highlights
Over the last trailing twelve months CSBR reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -109.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.27% | ||
| ROA | 8.26% | ||
| ROE | 59.76% | ||
| Debt/Equity | 0.01 |
CSBR Ownership
CSBR Latest News, Press Relases and Analysis
CSBR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.06 | 174.596B | ||
| DHR | DANAHER CORP | 22.99 | 135.34B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 125.61 | 40.288B | ||
| A | AGILENT TECHNOLOGIES INC | 16.85 | 31.614B | ||
| WAT | WATERS CORP | 20.44 | 28.451B | ||
| IQV | IQVIA HOLDINGS INC | 13.14 | 27.68B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.73 | 24.37B | ||
| ILMN | ILLUMINA INC | 23.1 | 18.238B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.55 | 17.307B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.11 | 12.874B | ||
| RVTY | REVVITY INC | 15.85 | 9.668B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.096B | ||
| TECH | BIO-TECHNE CORP | 22.95 | 7.636B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CSBR
Company Profile
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Company Info
IPO: 1988-11-30
CHAMPIONS ONCOLOGY INC
One University Plaza,, Suite 307
Hackensack NEW JERSEY 07601 US
CEO: Ronnie Morris
Employees: 213
Phone: 12018088400
CHAMPIONS ONCOLOGY INC / CSBR FAQ
What does CSBR do?
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Can you provide the latest stock price for CHAMPIONS ONCOLOGY INC?
The current stock price of CSBR is 6.2 USD. The price decreased by -0.8% in the last trading session.
What is the dividend status of CHAMPIONS ONCOLOGY INC?
CSBR does not pay a dividend.
What is the ChartMill rating of CHAMPIONS ONCOLOGY INC stock?
CSBR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for CSBR stock?
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 97.42% is expected in the next year compared to the current price of 6.2.
Would investing in CHAMPIONS ONCOLOGY INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CSBR.
Can you provide the number of employees for CHAMPIONS ONCOLOGY INC?
CHAMPIONS ONCOLOGY INC (CSBR) currently has 213 employees.